文献速递泌尿生殖腹部MR

膀胱憩室内肿瘤MRI特征的预后价值

Prognostic Utility of MRI Features in Intradiverticular Bladder Tumor.
PubMed 文献 · Acad Radiol · 2020-11-05

这项回顾性研究纳入31例膀胱憩室内肿瘤患者,评估MRI特征与总生存的关系。中位随访1044天,肿瘤>3cm、憩室颈受累、憩室外侵犯及可疑淋巴结与较低总生存相关(HR=3.6-8.1及4.3-6.3,p≤0.03)。肿瘤大小观察者间一致性优秀(ICC=0.991)。

要点

  • 肿瘤>3cm、憩室颈受累、憩室外侵犯、可疑淋巴结与较低总生存相关(HR=3.6-8.1及4.3-6.3,p≤0.03)。
  • VI-RADS评分观察者间一致性为fair(K=0.52,95%CI 0.22-0.82)。
  • 肿瘤大小观察者间一致性优秀(ICC=0.991,95%CI 0.982-0.996)。

核心结论

  • 膀胱憩室内肿瘤患者中,多项MRI特征与总生存显著相关。
  • 综合利用所有可获得的临床病理和影像信息可能改善预后评估。

研究设计与样本

  • 回顾性研究,纳入2008至2018年经电子病历和PACS数据库检索的31例连续膀胱憩室内肿瘤患者,均接受MRI检查。
  • 两名放射科医生独立评估MRI特征:大小(>3 vs ≤3 cm)、憩室颈受累、VI-RADS评分(>3 vs ≤3)、憩周脂肪浸润、额外肿瘤及可疑盆腔淋巴结。
  • 采用Kaplan-Meier分析估计总生存,Cox比例风险回归模型确定与临床病理及MRI特征的关系,组内相关系数(ICC)和Cohen kappa(K)评估观察者间一致性。

关键影像表现/征象

  • MRI上肿瘤大小>3 cm、憩室颈受累、憩室外侵犯及可疑淋巴结与较低总生存相关(HR=3.6-8.1及4.3-6.3 for the 2 radiologists,p≤0.03)。
  • 其他临床病理或MRI表现与生存无关(p=0.27-0.65)。

诊断标准与关键数值

  • MRI特征评估阈值:肿瘤大小>3 cm vs ≤3 cm;VI-RADS评分>3 vs ≤3。
  • 肿瘤大小观察者间一致性ICC=0.991(95%CI 0.982-0.996);VI-RADS一致性K=0.52(95%CI 0.22-0.82);其他特征K=0.61-0.79。

临床应用与阅片要点

  • 在膀胱憩室内肿瘤的MRI评估中,应关注肿瘤大小(>3 cm)、憩室颈受累、憩室外侵犯及可疑盆腔淋巴结,这些特征与总生存相关。
  • 综合利用临床病理和影像信息可能改善预后评估(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Intradiverticular bladder tumors (IDBT) are rare but clinically important, as they are difficult to assess endoscopically due to limited anatomic access and risk of perforation. MRI may be helpful in assessing IDBT and providing relevant staging and prognostic information.

PURPOSE: To assess MRI findings of IDBT and their relationship with overall survival.

METHODS: This retrospective study included 31 consecutive patients with IDBT undergoing MRI from 2008 to 2018 identified through electronic medical records and PACS database search. Two radiologists independently assessed the following MRI features: size (>3 vs ≤3 cm), diverticular neck involvement, Vesical Imaging-Reporting and Data System (VI-RADS) score (>3 vs ≤3), perivesical fat infiltration, additional tumors and suspicious pelvic lymph nodes. Overall survival was estimated using Kaplan-Meier analysis; and the relationship with clinicopathological and MRI features was determined using the Cox proportional-hazards regression model. Inter-reader agreement was assessed using intraclass correlation coefficients (ICC) and Cohen's kappa (K).

RESULTS: Median follow-up was 1044 days (interquartile range, 474-1952 days). Twenty-six (83.9%) patients underwent surgical treatment with or without neoadjuvant chemotherapy. On MRI, greater tumor size (>3 cm), diverticular neck involvement, perivesical extension, and suspicious lymph nodes were associated with lower overall survival (HR = 3.6-8.1 and 4.3-6.3 for the 2 radiologists, p ≤ 0.03). Other clinicopathological or MRI findings were not associated with survival (p = 0.27-0.65). Inter-reader agreement was excellent for tumor size (ICC = 0.991; 95% CI 0.982-0.996), fair for VI-RADS (K = 0.52, 95% CI, 0.22-0.82), and moderate for others (K = 0.61-0.79).

CONCLUSION: In patients with IDBT, several MRI features were significantly associated with overall survival. Utilizing all available clinicopathological and imaging information may improve estimation of prognosis.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Woo S, Ghafoor S, Becker AS, et al. Prognostic Utility of MRI Features in Intradiverticular Bladder Tumor. Acad Radiol. 2020. PMID: 33162319. doi:10.1016/j.acra.2020.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。